Cargando…
MDM4 actively restrains cytoplasmic mTORC1 by sensing nutrient availability
BACKGROUND: Many tumor-related factors have shown the ability to affect metabolic pathways by paving the way for cancer-specific metabolic features. Here, we investigate the regulation of mTORC1 by MDM4, a p53-inhibitor with oncogenic or anti-survival activities depending on cell growth conditions....
Autores principales: | Mancini, Francesca, Teveroni, Emanuela, Di Conza, Giusy, Monteleone, Valentina, Arisi, Ivan, Pellegrino, Marsha, Buttarelli, Marianna, Pieroni, Luisa, D’Onofrio, Mara, Urbani, Andrea, Pontecorvi, Alfredo, Mazzone, Massimiliano, Moretti, Fabiola |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5341177/ https://www.ncbi.nlm.nih.gov/pubmed/28270148 http://dx.doi.org/10.1186/s12943-017-0626-7 |
Ejemplares similares
-
Estrogens Counteract Platinum-Chemosensitivity by Modifying the Subcellular Localization of MDM4
por: Lucà, Rossella, et al.
Publicado: (2019) -
MDM4/HIPK2/p53 cytoplasmic assembly uncovers coordinated repression of molecules with anti-apoptotic activity during early DNA damage response
por: Mancini, F, et al.
Publicado: (2016) -
MDM4 (MDMX) and its Transcript Variants
por: Mancini, F, et al.
Publicado: (2009) -
mTORC1 restrains adipocyte lipolysis to prevent systemic hyperlipidemia
por: Paolella, Lauren M., et al.
Publicado: (2019) -
Analysis of human MDM4 variants in papillary thyroid carcinomas reveals new potential markers of cancer properties
por: Prodosmo, Andrea, et al.
Publicado: (2008)